Travere Therapeutics, Inc.
TVTX
50 insider filings · Latest: Jun 22, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Jun 16 8:46 PM | Timothy CoughlinDirector | Sale | 10,000 | $50.07 | $500.7K | 56,250(D) | View → |
| Jun 12, 2026 | Jun 16 8:42 PM | Roy D. BaynesDirector | Sale | 4,500 | $50.00 | $225.0K | 41,500(D) | View → |
| Jun 12, 2026 | Jun 12 8:05 PM | ROY BAYNES | Proposed Sale | 4,500 | $50.00 | $225.0K | — | View → |
| Jun 12, 2026 | Jun 12 4:20 PM | Coughlin Timothy | Proposed Sale | 10,000 | $50.04 | $500.4K | — | View → |
| May 15, 2026 | May 19 8:05 PM | Timothy CoughlinDirector | Sale | 3,250 | $43.49 | $141.3K | 52,250(D) | View → |
| May 15, 2026 | May 15 4:51 PM | Coughlin Timothy | Proposed Sale | 3,250 | $43.44 | $141.2K | — | View → |
| May 5, 2026 | May 7 12:00 AM | Roy D. BaynesDirector | Sale | 4,500 | $46.65 | $209.9K | 37,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Meckler Jeffrey ADirector | Sale | 8,000 | $45.00 | $360.0K | 87,500(D) | View → |
| May 6, 2026 | May 7 12:00 AM | William E. RoteChief Research Officer | Sale | 2,763 | $43.95 | $121.4K | 115,474(D) | View → |
| May 6, 2026 | May 7 12:00 AM | Elizabeth E ReedChief Legal Officer and GC | Sale | 2,076 | $43.95 | $91.2K | 105,211(D) | View → |
| May 5, 2026 | May 7 12:00 AM | Elizabeth E ReedChief Legal Officer and GC | Sale | 2,174 | $46.65 | $101.4K | 107,287(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Elizabeth E ReedChief Legal Officer and GC | Sale | 20,000 | $45.00 | $900.0K | 105,211(D) | View → |
| May 6, 2026 | May 7 12:00 AM | Jula InrigCHIEF MEDICAL OFFICER | Sale | 311 | $43.95 | $13.7K | 113,238(D) | View → |
| May 5, 2026 | May 7 12:00 AM | Jula InrigCHIEF MEDICAL OFFICER | Sale | 2,174 | $46.65 | $101.4K | 113,549(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Jula InrigCHIEF MEDICAL OFFICER | Sale | 20,000 | $45.00 | $900.0K | 111,473(D) | View → |
| May 5, 2026 | May 7 12:00 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Sale | 2,174 | $46.65 | $101.4K | 140,684(D) | View → |
| May 6, 2026 | May 7 12:00 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Sale | 22,500 | $43.95 | $988.9K | 432,886(D) | View → |
| May 6, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Sale | 310 | $43.95 | $13.6K | 118,658(D) | View → |
| May 5, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Sale | 2,181 | $46.65 | $101.7K | 118,968(D) | View → |
| May 6, 2026 | May 6 8:03 PM | CHRISTOPHER CLINE | Proposed Sale | 310 | $43.95 | $13.6K | — | View → |
Page 1 of 8
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | May 7 12:00 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 22,500 | — | 22,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 45,000 | — | 45,000(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Grant/Award | 8,500 | — | 8,500(D) | View → |
| May 4, 2026 | May 7 12:00 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Option Exercise | 4,250 | — | 4,250(D) | View → |
| May 1, 2026 | May 4 8:27 PM | Roy D. BaynesDirector | Option Exercise | 9,750 | $6.82 | 9,750(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | LYONS GARY ADirector | Option Exercise | 8,000 | $16.33 | 0(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Roy D. BaynesDirector | Option Exercise | 32,750 | $21.38 | 6,750(D) | View → |
| Apr 14, 2026 | Apr 16 8:05 PM | Sandra CalvinSVP, CHIEF ACCOUNTING OFFICER | Option Exercise | 15,250 | $22.40 | 19,500(D) | View → |
| Apr 14, 2026 | Apr 16 1:47 AM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 37,500 | $19.08 | 20,000(D) | View → |
| Apr 6, 2026 | Apr 7 10:17 PM | Roy D. BaynesDirector | Option Exercise | 10,000 | $26.52 | 0(D) | View → |
| Apr 1, 2026 | Apr 2 9:55 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 60,000 | $15.46 | 0(D) | View → |
| Apr 1, 2026 | Apr 2 9:55 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $15.46 | 45,000(D) | View → |
| Mar 16, 2026 | Mar 18 8:05 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $19.08 | 10,000(D) | View → |
| Feb 20, 2026 | Feb 24 9:05 PM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 60,000 | $15.46 | 60,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:10 PM | Elizabeth E ReedChief Legal Officer and GC | Option Exercise | 10,000 | $19.08 | 20,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Eric M DubeDirector, CHIEF EXECUTIVE OFFICER | Grant/Award | 303,600 | $33.10 | 303,600(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Jula InrigCHIEF MEDICAL OFFICER | Grant/Award | 75,000 | $33.10 | 75,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Christopher R. ClineCHIEF FINANCIAL OFFICER | Grant/Award | 75,000 | $33.10 | 75,000(D) | View → |
| Jan 31, 2026 | Feb 4 2:30 AM | Peter HeermaCHIEF COMMERCIAL OFFICER | Grant/Award | 69,640 | $33.10 | 69,640(D) | View → |